Conclusions:
1. The expression of apoptosis markers in patients with CIN II is significantly increased (BAX - 185.3 ± 17.4 H-score, bcl-2 - 143.9 ±
2.6 H-score) compared to expression with CIN I (BAX - 166.6 ± 18.4 H-score, bcl-2 - 138.2 ± 3.6 H-score).
2. The expression of immature dendritic cells CD1a (+) increases significantly with CIN II to 220.2 ± 18.4 H-score, CINI is 92.9 ± 6.7 H-score (p <0.05).
3. The expression of mature dendritic cells CD56 (+) increases significantly with a CIN I of 204.3 ± 9.8 H-score, with a CIN II of 60.9 ± 3.4 H-score, which allows us to consider these figures as prediction markers .
4. The presence of a correlation relationship of average strength between the indices of bcl-2 and CD1a (r = 0.54), indicating that the pathogenetic processes of cell proliferation are related.
1.Cervical Cancer Markers: Epigenetics and microRNAs. Laengsri V1,2, Kerdpin U3, Plabplueng C1,2, Treeratanapiboon L4, Nuchnoi P1,2. Lab Med. 2018 Mar 21;49(2):97-111. doi: 10.1093/labmed/lmx080.
2.Adam, E., Z. Berkova, Z. Daxnerova, J. Icenogle, W. C. Reeves, and R. H. Kaufman. 2000. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease. Am. J. Obstet. Gynecol. 182:257-264. [PubMed]
3.Kubicka-Sierszen A, Grzegorczyk JŁ. The influence of infectious factors on dendritic cell apoptosis. Arch Med Sci. 2015;11:1044–1051. [PMC free article] [PubMed]
4.DasGupta T, Nweze EI, Yue H, Wang L, Jin J, Ghosh SK, Kawsar HI, Zender C, Androphy EJ, Weinberg A, et al. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53. Oncotarget. 2016;7:27430–27444. doi: 10.18632/oncotarget.8443.
5.Liu Y, Chiriva-Internati M, Grizzi F, Salati E, Roman JJ, Lim S, Hermonat PL. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther. 2001;8:948–957. doi: 10.1038/sj.cgt.7700391.